Digital Look

Ark Therapeutics Group (AKT)

Sector:

Pharmaceuticals & Biotechnology

Index:

techMARK Medisc. Index

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

2.82p

Change Today:

0.040p
52 Week High: 5.35p
52 Week Low: 2.70p

Currency: UK Pounds
Shares Issued: 209.28m
Volume: 737,270

Market Cap: £5.89m
RiskGrade: 371
Beta: 0.41

Update - Ark Therapeutics Group is near the top of the FTSE techMARK Medisc. Inde - will it stay here? Have a look at Ark Therapeutics Group's chart Find out more
Update -Ark Therapeutics Group is a top riser in its sector - discover how to spread bet similar stocks Find out more

AKT Overview

Ark Therapeutics Group is in the pharmaceuticals & biotechnology sector and is currently trading at 2.82p per share. In the last year Ark Therapeutics Group's share price has ranged from 2.70p to 5.35p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (30-05-2012)

6 Month Chart

More Ark Therapeutics Group charts

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	n/a	n/a
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	n/a	n/a
Pr/Book	n/a

	Latest	F'cast
Revenue	n/a	n/a
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

AKT Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-07	1.12	(20.02)	(11.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-08	0.93	(17.60)	(8.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-09	1.39	(20.21)	(9.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-10	0.76	(16.94)	(6.77)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-11	7.13	(4.44)	(1.79)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AKT Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-12	5.10	(7.53)	(3.30)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-13	7.63	(5.43)	(2.30)p	n/a	n/a	n/a	n/a	0.0%

Ark Therapeutics Group forecasts

AKT Company Announcements

Holding(s) in Company	18-May-2012	12:02	RNS
Director Dealings	18-May-2012	12:01	RNS
Result of AGM	18-May-2012	11:57	RNS

More Ark Therapeutics Group akt company announcements

AKT ShareCast News

JD Wetherspoon founder gets some more in	18-May-2012	ShareCast
Small caps round-up: Ark Therapeutics, Volex, Go...	02-May-2012	ShareCast
Small caps round-up: Plastics Capital, Vislink, ...	25-Apr-2012	ShareCast

More Ark Therapeutics Group ShareCast news

AKT Top Newspaper Links

Ark gains on hopes for cancer drug	31-Jul-2008	The Independent
Need to know	31-May-2008	Times
Ark perks up after regulators say brain tumour g...	06-Jan-2007	Telegraph

Latest AKT Director Deals

Traded	Action	Notifier	Price	Amount	Value
17-May-12	Buy	Peter Keen	2.85p	750,000	£21,375.00
14-Mar-12	Buy	Martyn Williams	3.63p	274,000	£9,946.20
14-Mar-12	Buy	Charles Spicer	3.60p	551,395	£19,850.22

More Ark Therapeutics Group director deals

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

AKT Market Data

Currency	UK Pounds
Share Price	2.82p
Change Today	0.040p
% Change	1.44 %
52 Week High	5.35p
52 Week Low	2.70p
Volume	737,270
Shares Issued	209.28m
Market Cap	£5.89m
Beta	0.41
RiskGrade	371